Boehringer Ingelheim Hits Milestone in CKD: Promising Phase II Results with Aldosterone Synthase Inhibitor + Empagliflozin

Phase II results demonstrated significant albuminuria reductions by up to 39.5% vs. placebo when BI 690517, a novel selective aldosterone synthase inhibi...

November 06, 2023 | Monday | News
MoonLake Immunotherapeutics Reveals Breakthrough Phase 2 Results for Nanobody® Sonelokimab in Psoriatic Arthritis

First placebo-controlled randomized trial in active psoriatic arthritis (PsA) using a Nanobody® to report positive topline results in support of pote...

November 06, 2023 | Monday | News
Pfizer Advances GLP-1 Receptor Agonist PF-06954522 to Phase 1 Trial with Sosei Heptares Collaboration

Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has been notified by Pfizer that it has entered a new oral s...

November 06, 2023 | Monday | News
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics

Novogene is a leading provider of genomic services and solutions offering extensive next generation sequencing (NGS) capacity and bioinformatics expertise....

November 06, 2023 | Monday | News
Bayer Unveils New Biomarker Study Supporting Kerendia®'s Mechanism in CKD Patients with T2D

At the American Society of Nephrology’s (ASN) Kidney Week 2023, Bayer today announced pharmacodynamic data on Kerendia® (finerenone), the first n...

November 03, 2023 | Friday | News
Shuttle Pharma Advances Prostate Cancer Biomarker Program via Exclusive License

The intellectual property was originally developed through a collaboration of Shuttle Pharma scientists with investigators from Georgetown University. The ...

November 02, 2023 | Thursday | News
Twist Bioscience Introduces Dual Index Adapters for PCR-free Whole Genome Sequencing

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing and methylation detection Enables multiplexing and...

November 02, 2023 | Thursday | News
Revvity's CEO Prahlad Singh Navigates Stormy Q3 Waters, Pledges Stronger Future Amid Market Uncertainty

Revenue of $671 million; (6)% reported growth; (7)% organic growth; 1% non-COVID organic growth GAAP EPS of $0.08; Adjusted EPS from continuing oper...

October 31, 2023 | Tuesday | Company results
QIAGEN CEO Thierry Bernard Hails Remarkable Quarter, Sees Bright Future on the Horizon

Q3 2023: Net sales of $476 million (-5% at actual rates, -6% at constant exchange rates, CER); diluted EPS of $0.34 and adjusted diluted EPS of $0.50 // Ne...

October 31, 2023 | Tuesday | Company results
Bio-Rad CEO, Norman Schwartz, Discusses Q3 Results and Adjusts 2023 Outlook Amid Biopharma Challenges

  Third-quarter 2023 total net sales were $632.1 million, a decrease of 7.1 percent compared to $680.8 million reported for the third quarter of 20...

October 30, 2023 | Monday | Company results
Data and AI in Life Sciences: Shaping the Future - An Exclusive Interview with Mr. Shakthi Nagappan, CEO of Telangana Life Sciences

In a rapidly evolving world where data and artificial intelligence have become paramount, BioAsia 2024 presents a theme that transcends traditional boundar...

October 27, 2023 | Friday | Interaction
Marc Casper's Leadership Propels Thermo Fisher to Strong Q3 Performance Amid Market Challenges

Third Quarter 2023 Highlights Third quarter revenue was $10.57 billion, 1% lower versus the same quarter last year. Core organic revenue growth was 1%. ...

October 26, 2023 | Thursday | Company results
Accenture Acquires ConcentricLife to Strengthen Healthcare Marketing in Life Sciences

Founded in 2002, ConcentricLife is recognized as one of the MM+M Agency 100, the industry's definitive guide to the top agencies in the health landscape. I...

October 26, 2023 | Thursday | News
Evonik Introduces World’s First Bio-Circular PA12 3D Printing Powder

100 percent substitution of fossil feedstock with bio-circular raw material from waste cooking oil 74 percent less CO2 emissions compared to own c...

October 25, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close